Should aPS/PT Be Incorporated into the Routine Serological Tests in the Diagnosis of Antiphospholipid Syndrome?

REFERENCES

1. 1.↵
   1. Zohoury N,
   2. Bertolaccini ML,
   3. Rodriguez-Garcia JL,
   4. Shums Z,
   5. Ateka-Barrutia O,
   6. Sorice M,
   7. et al.

   Closing the serological gap in the antiphospholipid syndrome: The value of “non-criteria” antiphospholipid antibodies. J Rheumatol 2017;44:1597–602.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Amengual O,
   2. Forastiero R,
   3. Sugiura-Ogasawara M,
   4. Otomo K,
   5. Oku K,
   6. Favas C,
   7. et al.

   Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study. Lupus 2017;26:266–76.

   OpenUrl
3. 3.↵
   1. Zhang S,
   2. Wu Z,
   3. Zhang W,
   4. Zhao J,
   5. Norman GL,
   6. Zeng X,
   7. et al.

   Antibodies to phosphatidylserine/prothrombin (aPS/PT) enhanced the diagnostic performance in Chinese patients with antiphospholipid syndrome. Clin Chem Lab Med 2018;56:939–46.

   OpenUrl
4. 4.↵
   1. Hoxha A,
   2. Ruffatti A,
   3. Mattia E,
   4. Meneghel L,
   5. Tonello M,
   6. Salvan E,
   7. et al.

   Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome. Clin Chem Lab Med 2015;53:1265–70.

   OpenUrl
5. 5.↵
   1. Miyakis S,
   2. Lockshin MD,
   3. Atsumi T,
   4. Branch DW,
   5. Brey RL,
   6. Cervera R,
   7. et al.

   International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (aps). J Thromb Haemost 2006;4:295–306.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Zhu L,
   2. Li C,
   3. Liu N,
   4. Yang X,
   5. Jia RL,
   6. Mu R,
   7. et al.

   Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients. Clin Rheumatol 2017;36:401–6.

   OpenUrl
7. 7.↵
   1. Shi H,
   2. Zheng H,
   3. Yin YF,
   4. Hu QY,
   5. Teng JL,
   6. Sun Y,
   7. et al.

   Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid syndrome. Clin Chem Lab Med 2018;56:614–24.

   OpenUrl
8. 8.↵
   1. Bertolaccini ML,
   2. Amengual O,
   3. Atsumi T,
   4. Binder WL,
   5. de Laat B,
   6. Forastiero R,
   7. et al.

   ‘Non-criteria’ aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010. Lupus 2011;20:191–205.

   OpenUrlCrossRefPubMed